We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Liquid Biopsies – News and Features

A purple-gloved hand holding two test tubes filled with blood.

ctDNA Analyses Could Help Guide Immunotherapy for Non-Small Cell Lung Cancer Patients

Measuring ctDNA could offer a new approach to identifying non-small cell lung cancer patients in greater need of additional treatments during immunotherapy.
A medical professional taking blood from a patient.

ctDNA Shows Promise as a Prognostic Biomarker for Advanced Melanoma

Measuring circulating tumor DNA may lead to alternative treatment options and better outcomes for patients with advanced BRAF-negative melanoma, report investigates in The Journal of Molecular Diagnostics.
Two vials of blood.

Liquid Biopsy Could Guide Treatment Decisions for Oligometastatic Lung Cancer

A new study could help doctors decide the best treatment strategy for patients with lung cancer that has spread beyond the original tumor but has not spread all over the body.
A woman breastfeeding an infant.

Early-Stage Breast Cancers Detected From Breastmilk

Researchers have shown for the first time that breast milk from breast cancer patients contains tumor DNA, known as circulating tumor DNA (ctDNA). This can be detected through liquid biopsy in breast milk.
A purple gloved hand holds two blood test tubes.

New RNA Liquid Biopsy Platform Improves Cancer Detection

A new liquid biopsy platform has been developed that uses RNA "dark matter" to diagnose cancer types including pancreatic, lung and esophageal, in the early stages.
Illustration of DNA double helices on a yellow and pink polka dot background.

Oncology Researchers: Are You Getting the Most From Your Digital PCR Data?

This article discusses what good dPCR data looks like, how substandard equipment can detract from data quality and what oncology researchers can do to get high-quality dPCR data that will provide accurate and efficient insight into tumor load.
Floating cells with transparent membranes.
Industry Insight

Unlocking the “Morpholome” With AI-Powered Imaging

Technology Networks had the pleasure of speaking with Dr. Maddison Masaeli, co-founder and chief executive officer at Deepcell to learn about the REM-I platform, a single-cell analysis tool that utilizes AI-powered imaging to magnify insights into a cell’s phenotype and function.
Computer-generated image the gut and gut microbes.

Bacteria Detect DNA Shed by Colon Cancer Tumors in Mice

Engineered bacteria can detect tumor DNA shed by colon cancers into the gastrointestinal (GI) tract in mice, creating the potential for their use as biosensors to detect and respond to disease.
A person taking a blood sample from a patient's arm.

Machine Learning Could Boost Liquid Biopsy Cancer Diagnoses

Short pieces of DNA floating in the bloodstream of cancer patients can help doctors diagnose specific types of cancer and choose the most effective treatment.
Illustration showing the regular latticework of micropillars in the microfluidic device used in the study.

Advancing Antigen Discovery With Microfluidics Automation for Sparse Samples

An automated and cost-effective workflow in immunopeptidomics, utilizing microfluidics technology, has been created that overcomes limitations in sample preparation and could be a powerful tool for tumor antigen discovery in sparse samples.